UTHR — United Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00
- $11.20bn
- $8.90bn
- $2.33bn
- 98
- 64
- 86
- 96
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 1,486 | 1,835 | 1,931 | 2,839 | 2,994 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 151 | 157 | 199 | 220 | 279 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 1,865 | 2,167 | 2,324 | 3,380 | 3,551 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 743 | 732 | 781 | 862 | 1,045 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 3,913 | 4,615 | 5,169 | 6,045 | 7,167 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 463 | 323 | 305 | 343 | 804 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 1,133 | 1,220 | 1,210 | 1,248 | 1,182 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 2,780 | 3,395 | 3,959 | 4,797 | 5,985 |
Total Liabilities & Shareholders' Equity | 3,913 | 4,615 | 5,169 | 6,045 | 7,167 |
Total Common Shares Outstanding |